BetterLife Pharma Inc (OTCMKTS: BETRF) has announced positive results after a BETR-001 Preclinical neuroplasticity study in rat neurons. This study was in partnership with Dr. Argel...
BetterLife Pharma Inc. (OTCMKTS: BETRF) has announced that its subsidiary Altum Pharmaceuticals Inc. and Pontifical Universidad Catolica de Chile have finalized the Phase 1 part of...
Betterlife Pharma Inc. (OTCMKTS: BETRF) has announced receipt of the first neurological receptor functional binding data set in its flagship compound, 2-Bromo-LSD (TD-0148A) TD-0148A is a...
BetterLife Pharma Inc. (OTCMKTS: BETRF) has announced positive in-vitro data from Dr. Stephen Barr’s Lab at the ultra-modern ImPaKT Facility at Western University Schulich School of...
BetterLife Pharma Inc (OTCMKTS: BETRF) has announced that it has registered its first patient for the Phase 1 part of Phase 1-2 randomized placebo-controlled in COVID-19...
BetterLife Pharma Inc (OTCMKTS: BETRF), in a statement, announced that it has entered into a formal agreement with the Laboratory of Dr. John McCorvy at the...
There are reportedly more than 265 million people across the globe suffering from depression. Unfortunately, the only available treatment is psychedelics, which again has its drawbacks,...
BetterLife Pharma Inc (OTCMKTS: BETRF) recently updated about funding from the Mitacs Accelerate program in response to its joint application and the Department of Neuroscience, Carleton...
